OLIGODENDROGLIOMA
Clinical trials for OLIGODENDROGLIOMA explained in plain language.
Never miss a new study
Get alerted when new OLIGODENDROGLIOMA trials appear
Sign up with your email to follow new studies for OLIGODENDROGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem cells and immunotherapy join forces against childhood brain tumors
Disease control OngoingThis early-stage trial tests a new approach for children whose high-grade glioma has come back after standard treatments. It combines specially grown stem cells with an immunotherapy drug called nivolumab. The main goals are to see if the treatment is safe and possible to deliver…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
Virus therapy takes on brain cancer in early trial
Disease control OngoingThis early-phase study tests a modified virus designed to attack brain tumor cells that have come back or grown despite previous treatment. About 62 adults with certain types of brain cancer will receive the virus directly into the tumor, sometimes with a drug to boost the immune…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
New drug combo targets recurrent brain tumors in early trial
Disease control OngoingThis early-phase study tests whether combining vorasidenib (a targeted therapy) with pembrolizumab (an immunotherapy) is safe and can boost the immune system's attack on recurrent IDH-1 mutant gliomas, a type of brain tumor. About 60 adults with grade 2 or 3 tumors will receive t…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
New camera could help surgeons spot brain tumors Mid-Operation
Diagnosis TerminatedThis early trial tests a new imaging device called qOBM that helps surgeons see the edges of brain tumors during surgery. About 24 adults with certain brain cancers will be enrolled. The goal is to check if the device is safe and reliable for finding tumor margins.
Matched conditions: OLIGODENDROGLIOMA
Phase: NA • Sponsor: Emory University • Aim: Diagnosis
Last updated May 04, 2026 16:30 UTC